VILOBELIMAB (vil oh bel i mab) treats severe COVID-19 in people who are hospitalized. It works by slowing down an overactive immune system, which prevents worsening symptoms. It is a monoclonal antibody. The FDA has allowed the emergency use of this medication.


There is no lifestyle interaction information available for this medication.